Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review
- PMID: 26218943
Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review
Abstract
Background: Serotonin syndrome is a mild to potentially life-threatening syndrome associated with excessive serotonergic activity within the central nervous system. Serotonin syndrome is associated with medication use, drug interactions, and overdose. While serotonin syndrome is often associated with the use of selective serotonin inhibitors (SSRI), an increasing number of reports are being presented involving the use of tramadol.
Methods: This review article contains an overview of serotonin syndrome while specifically looking at tramadol's pharmacology and risk factors for serotonin syndrome. With tramadol's increasing popularity, the goal of this article is to make physicians more alert and aware of this potential side effect associated with tramadol.
Conclusions: In conclusion, with the increasing incidence of serotonin syndrome, prescribing physicians should be aware of and educate their patients on the potential side effects of tramadol. It is important that the prescribing physician reviews patient medications for concurrent serotonergic drugs and monitors for potential abuse.
Similar articles
-
Transient serotonin syndrome caused by concurrent use of tramadol and selective serotonin reuptake inhibitor.Am J Case Rep. 2014 Dec 19;15:562-4. doi: 10.12659/AJCR.892264. Am J Case Rep. 2014. PMID: 25540831 Free PMC article.
-
Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures.Am J Med. 2018 Nov;131(11):1382.e1-1382.e6. doi: 10.1016/j.amjmed.2018.04.025. Epub 2018 May 10. Am J Med. 2018. PMID: 29752906 Review.
-
Serotonin syndrome secondary to tramadol and citalopram.Age Ageing. 2011 Jul;40(4):528. doi: 10.1093/ageing/afr017. Epub 2011 Mar 16. Age Ageing. 2011. PMID: 21414947 No abstract available.
-
Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors.Ann Pharmacother. 2012 Dec;46(12):1712-6. doi: 10.1345/aph.1Q748. Epub 2012 Dec 4. Ann Pharmacother. 2012. PMID: 23212934 Review.
-
Serotonin syndrome with fluoxetine plus tramadol.J R Soc Med. 1999 Sep;92(9):474-5. doi: 10.1177/014107689909200915. J R Soc Med. 1999. PMID: 10645303 Free PMC article. No abstract available.
Cited by
-
Safety and Efficacy of Combined Injection of Pure-μ-Opioid Agonist with Tramadol as an Opioid Induction Agent for Opioid-Naïve Cancer Patients.Palliat Med Rep. 2024 Aug 5;5(1):340-349. doi: 10.1089/pmr.2023.0061. eCollection 2024. Palliat Med Rep. 2024. PMID: 39144134
-
Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis.Orphanet J Rare Dis. 2024 Jun 2;19(1):221. doi: 10.1186/s13023-024-03227-5. Orphanet J Rare Dis. 2024. PMID: 38825678 Free PMC article. Review.
-
Risk Factors for Respiratory Depression Associated with Tramadol Based on the Global Pharmacovigilance Database (VigiBase).Pharmaceuticals (Basel). 2024 Feb 5;17(2):205. doi: 10.3390/ph17020205. Pharmaceuticals (Basel). 2024. PMID: 38399420 Free PMC article.
-
Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic cancer pain.Support Care Cancer. 2024 Jan 22;32(2):121. doi: 10.1007/s00520-024-08323-7. Support Care Cancer. 2024. PMID: 38252311
-
Opioid Therapy and Implications for Oxidative Balance: A Clinical Study of Total Oxidative Capacity (TOC) and Total Antioxidative Capacity (TAC).J Clin Med. 2023 Dec 22;13(1):82. doi: 10.3390/jcm13010082. J Clin Med. 2023. PMID: 38202088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources